Cambridge, Massachusetts — Seqirus, Inc. has been awarded a $69,672,000.00 federal contract with the Department of Health and Human Services (HHS); Office of Assistant Secretary for Preparedness and Response. to provide services to the federal government in Cambridge. According to the company website, CSL Seqirus, part of the CSL Group, is the new global company created from the combined strength and expertise of bioCSL and the influenza vaccines business formerly owned by Novartis. In July 2015, the two businesses joined forces to create Seqirus, now the second largest influenza vaccine company in the world. With extensive research and production expertise and manufacturing plants in the US, UK, Germany and Australia, CSL Seqirus is a transcontinental partner in pandemic preparedness and a major contributor to the prevention and control of influenza globally. CSL Seqirus has a workforce of over 3,000 employees, significant manufacturing capacity and a commercial presence in over 20 countries. In Australia and New Zealand, CSL Seqirus markets a comprehensive range of vaccines and specialty pharmaceutical products. It also manufactures products of national significance for Australia, including antivenoms and Q fever vaccine.

To learn more about Seqirus, Inc. please visit http://www.seqirus.com/

Contact Information:
Seqirus, Inc.
475 Green Oaks Pkwy
Holly Springs, NC 27540
Phone: 919-577-5000
Industry: 8741 Management Services

SOURCE: http://www.intelligence360.io
Copyright (c) 2022 SI360 Inc. All rights reserved